News & Media

Latest Press Release

April 3, 2020

BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19

Westport, CT, April 03, 2020 (GLOBE NEWSWIRE) -- Introduction to ViralClear management and scientific team Strategy for rapid FDA advancement of Vicromax(tm) Update on BioSig core business developments and commercialization plans BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform, today announced that it intends to provide a public business update via teleconference regarding its…

Read More